Mumbai, April 13 -- Piramal Pharma announced that US FDA has issued an Establishment Inspection Report (EIR) for its manufacturing facility located at Lexington, (Kentucky, USA) with VAI (Voluntary Action Indicated).

Receipt of said EIR marks successful closure of the inspection.

Published by HT Digital Content Services with permission from Capital Market....